Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-25 @ 4:56 AM
Ignite Modification Date: 2025-12-25 @ 4:56 AM
NCT ID: NCT05290818
Eligibility Criteria: Inclusion Criteria: * Listed for elective primary TKA for end stage medial compartment osteoarthritis * Intact anterior cruciate ligament * Full thickness and good quality lateral cartilage * Correctable intra-articular varus deformity and intact medial collateral ligament * American Society of Anesthesiologists (ASA) grades 1 and 2 * Male or female, age 50 - 75 at the time of listing for surgery * Suitable candidate for a cruciate retaining TKA (Triathlon prosthesis) and a UKA Exclusion Criteria: * Varus deformity of \> 20 degrees * Fixed flexion of \>10 degrees * Patient is unable to comply with the study protocol (incl. refusal for CT scan) or functional assessments * Female participants who are pregnant, lactating or planning pregnancy during the course of the study * Requires patella resurfacing or lateral compartment has significant OA * Inability to understand the patient information for the study, provide written informed consent or answer study questionnaires for cognitive or language reasons * Inflammatory disorder e.g. rheumatoid arthritis * Symptomatic foot, hip or spine pathology * Prior surgery (other than arthroscopy) or septic arthritis of the knee * Any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the study,
Healthy Volunteers: False
Sex: ALL
Minimum Age: 50 Years
Maximum Age: 75 Years
Study: NCT05290818
Study Brief:
Protocol Section: NCT05290818